Chronic Polyradiculoneuritis
Symptoms, Doctors, Treatments, Advances & More

Chronic Polyradiculoneuritis Overview

Save information for later
Sign Up

Learn About Chronic Polyradiculoneuritis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Polyradiculoneuritis Local Doctors?
Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine
Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine
Referral may be required

M Health Fairview EMG Clinic Minneapolis

909 Fulton Street Southeast, Floor 3, 
Minneapolis, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jeffrey Allen is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Minneapolis, Minnesota. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Polyradiculoneuritis, Multifocal Motor Neuropathy, and Guillain-Barre Syndrome. Dr. Allen is board certified in Neurology: American Board Of Psychiatry And Neurology, 2008 and Neuromuscular Medicine: American Board Of Psychiatry And Neurology, 2011. Dr. Allen is currently accepting new patients.

Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine | Neurosurgery
Elite in Chronic Polyradiculoneuritis
Neurology | Neuromusculoskeletal Medicine | Neurosurgery
Referral may be required

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
Languages Spoken:
English
Offers Telehealth

Marinos Dalakas is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Dalakas is rated as an Elite provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy. Dr. Dalakas is board certified in Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Chronic Polyradiculoneuritis
Distinguished in Chronic Polyradiculoneuritis
Referral may be required

Avera Medical Group Marshall — Bruce St

300 S Bruce St, 
Marshall, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Justin Persson is a Neurologist practicing medicine in Marshall, Minnesota. Dr. Persson is rated as a Distinguished provider by MediFind in the treatment of Chronic Polyradiculoneuritis. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Memory Loss, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, Miller-Fisher Syndrome, and Gamma Knife Radiosurgery. Dr. Persson is board certified in American Board Of Psychiatry And Neurology - Neurology. Dr. Persson is currently accepting new patients.

What are the latest Chronic Polyradiculoneuritis Clinical Trials?
An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Summary: The main goal of the study is to find out whether XEMBIFY, given once a week under the skin, provides similar levels of immunoglobulin G in the blood over time as Gamunex-C, which is given into a vein once every 3 weeks in people with CIDP. Participants with CIDP will first have up to 28 days of screening to make sure they can join the study. Those who qualify will then start a 19-week treatment p...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of DNTH103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Summary: The purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).